• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

万古霉素中介耐药性发展过程中的新型突变位点 。 你提供的原文似乎不完整,句末“in.”后面应该还有具体内容。

Novel Mutation Sites in the Development of Vancomycin- Intermediate Resistance in .

作者信息

Wang Yubing, Li Xiaoli, Jiang Libo, Han Wentao, Xie Xiangming, Jin Yi, He Xiaoqing, Wu Rongling

机构信息

College of Biological Sciences and Biotechnology, Beijing Forestry University Beijing, China.

College of Biological Sciences and Biotechnology, Beijing Forestry UniversityBeijing, China; Center for Computational Biology, Beijing Forestry UniversityBeijing, China.

出版信息

Front Microbiol. 2017 Jan 10;7:2163. doi: 10.3389/fmicb.2016.02163. eCollection 2016.

DOI:10.3389/fmicb.2016.02163
PMID:28119680
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5222870/
Abstract

Increased use of vancomycin has led to the emergence of vancomycin-intermediate (VISA). To investigate the mechanism of VISA development, 39 methicillin-susceptible strains and 3 MRSA strains were treated with vancomycin to induce non-susceptibility, and mutations in six genes were analyzed. All the strains were treated with vancomycin for 60 days. MICs were determined by the agar dilution and -test methods. Vancomycin was then removed to assess the stability of VISA strains and mutations. Following 60 days of vancomycin treatment , 29/42 VISA strains were generated. The complete sequences of , and were compared with those in the parental strains. Seven missense mutations including four novel mutations (L466S in , R232K in , I594M in , and A111T in ) were detected frequently in strains with vancomycin MIC ≥ 12 μg/mL. Jonckheere-Terpstra trend test indicated these mutations might play an important role during VISA evolution. After the vancomycin treatment, strains were passaged to vancomycin-free medium for another 60 days, and the MICs of all strains decreased. Our results suggest that , and are more important than and in VISA development.

摘要

万古霉素使用的增加导致了万古霉素中介金黄色葡萄球菌(VISA)的出现。为了研究VISA产生的机制,用万古霉素处理39株甲氧西林敏感菌株和3株耐甲氧西林金黄色葡萄球菌(MRSA)菌株以诱导其产生耐药性,并分析6个基因的突变情况。所有菌株均用万古霉素处理60天。通过琼脂稀释法和E试验方法测定最低抑菌浓度(MIC)。然后去除万古霉素以评估VISA菌株的稳定性和突变情况。经过60天的万古霉素处理后,产生了29/42株VISA菌株。将这些菌株的、和的完整序列与亲本菌株的进行比较。在万古霉素MIC≥12μg/mL的菌株中频繁检测到7个错义突变,包括4个新突变(中的L466S、中的R232K、中的I594M和中的A111T)。Jonckheere-Terpstra趋势检验表明这些突变可能在VISA进化过程中起重要作用。万古霉素处理后,将菌株转接至不含万古霉素的培养基中再培养60天,所有菌株的MIC均下降。我们的结果表明,在VISA产生过程中,、和比和更重要。

相似文献

1
Novel Mutation Sites in the Development of Vancomycin- Intermediate Resistance in .万古霉素中介耐药性发展过程中的新型突变位点 。 你提供的原文似乎不完整,句末“in.”后面应该还有具体内容。
Front Microbiol. 2017 Jan 10;7:2163. doi: 10.3389/fmicb.2016.02163. eCollection 2016.
2
Contribution of selected gene mutations to resistance in clinical isolates of vancomycin-intermediate Staphylococcus aureus.某些基因突变对耐万古霉素中间葡萄球菌临床分离株耐药性的贡献。
Antimicrob Agents Chemother. 2012 Nov;56(11):5845-51. doi: 10.1128/AAC.01139-12. Epub 2012 Sep 4.
3
Role of stop codons in development and loss of vancomycin non-susceptibility in methicillin-resistant Staphylococcus aureus.终止密码子在耐甲氧西林金黄色葡萄球菌的发育和万古霉素不敏感性丧失中的作用。
J Antimicrob Chemother. 2012 Sep;67(9):2101-6. doi: 10.1093/jac/dks171. Epub 2012 May 29.
4
Effect of genetic background on the evolution of Vancomycin-Intermediate (VISA).遗传背景对万古霉素中介金黄色葡萄球菌(VISA)进化的影响。
PeerJ. 2021 Jul 13;9:e11764. doi: 10.7717/peerj.11764. eCollection 2021.
5
Reconstruction of the Vancomycin-Susceptible Phenotype From a Vancomycin-Intermediate XN108.从万古霉素中介型XN108重建万古霉素敏感表型。
Front Microbiol. 2018 Nov 28;9:2955. doi: 10.3389/fmicb.2018.02955. eCollection 2018.
6
WalK(S221P), a naturally occurring mutation, confers vancomycin resistance in VISA strain XN108.WalK(S221P),一种自然发生的突变,赋予万古霉素中介金黄色葡萄球菌菌株XN108对万古霉素的耐药性。
J Antimicrob Chemother. 2017 Apr 1;72(4):1006-1013. doi: 10.1093/jac/dkw518.
7
The effect of subinhibitory concentration of chlorhexidine on the evolution of vancomycin-intermediate Staphylococcus aureus and the induction of mutations in walKR and vraTSR systems.亚抑菌浓度洗必泰对万古霉素中介金黄色葡萄球菌进化和 walKR 及 vraTSR 系统突变诱导的影响。
Infect Genet Evol. 2021 Jan;87:104628. doi: 10.1016/j.meegid.2020.104628. Epub 2020 Nov 7.
8
A novel mutation of walK confers vancomycin-intermediate resistance in methicillin-susceptible Staphylococcus aureus.一种新型 walK 突变使耐甲氧西林金黄色葡萄球菌对万古霉素表现出中介耐药性。
Int J Med Microbiol. 2021 Feb;311(2):151473. doi: 10.1016/j.ijmm.2021.151473. Epub 2021 Jan 6.
9
Mutation of RNA polymerase beta subunit (rpoB) promotes hVISA-to-VISA phenotypic conversion of strain Mu3.RNA 聚合酶β亚基(rpoB)突变促进 Mu3 株 hVISA 至 VISA 表型转化。
Antimicrob Agents Chemother. 2011 Sep;55(9):4188-95. doi: 10.1128/AAC.00398-11. Epub 2011 Jul 11.
10
Generation of a vancomycin-intermediate Staphylococcus aureus (VISA) strain by two amino acid exchanges in VraS.万古霉素中介金黄色葡萄球菌(VISA)通过 vraS 中的两个氨基酸交换产生。
J Antimicrob Chemother. 2014 Dec;69(12):3190-8. doi: 10.1093/jac/dku297. Epub 2014 Aug 6.

引用本文的文献

1
Unraveling novel mutation patterns and morphological variations in two dalbavancin-resistant MRSA strains in Austria using whole genome sequencing and transmission electron microscopy.运用全基因组测序和透射电子显微镜技术揭示奥地利两株达巴万星耐药 MRSA 菌株中的新型突变模式和形态变化。
BMC Infect Dis. 2024 Sep 2;24(1):899. doi: 10.1186/s12879-024-09797-w.
2
Teicoplanin associated gene inactivation increases persister cell formation in .替考拉宁相关基因失活增加了……中持留菌细胞的形成。 (原文句子不完整,“in”后面缺少具体内容)
Front Microbiol. 2023 Oct 13;14:1241995. doi: 10.3389/fmicb.2023.1241995. eCollection 2023.
3
Adaptive Laboratory Evolution of Resistance to Vancomycin and Daptomycin: Mutation Patterns and Cross-Resistance.

本文引用的文献

1
Vancomycin susceptibility in methicillin-resistant Staphylococcus aureus is mediated by YycHI activation of the WalRK essential two-component regulatory system.耐甲氧西林金黄色葡萄球菌对万古霉素的敏感性是由WalRK必需双组分调节系统的YycHI激活介导的。
Sci Rep. 2016 Sep 7;6:30823. doi: 10.1038/srep30823.
2
Population Genomics of Reduced Vancomycin Susceptibility in Staphylococcus aureus.金黄色葡萄球菌中万古霉素低敏性的群体基因组学研究。
mSphere. 2016 Jul 20;1(4). doi: 10.1128/mSphere.00094-16. eCollection 2016 Jul-Aug.
3
Microbiological effects of sublethal levels of antibiotics.
对万古霉素和达托霉素耐药性的适应性实验室进化:突变模式与交叉耐药性
Antibiotics (Basel). 2023 May 18;12(5):928. doi: 10.3390/antibiotics12050928.
4
Concordance between Antimicrobial Resistance Phenotype and Genotype of from Healthy Dogs.健康犬类抗菌药物耐药表型与基因型的一致性
Antibiotics (Basel). 2022 Nov 15;11(11):1625. doi: 10.3390/antibiotics11111625.
5
Multiomics characterization of methicillin-resistant Staphylococcus aureus (MRSA) isolates with heterogeneous intermediate resistance to vancomycin (hVISA) in Latin America.拉丁美洲万古霉素中介耐药金黄色葡萄球菌(hVISA)异质性耐药分离株的多组学特征。
J Antimicrob Chemother. 2022 Dec 23;78(1):122-132. doi: 10.1093/jac/dkac363.
6
Cervimycin-Resistant Staphylococcus aureus Strains Display Vancomycin-Intermediate Resistant Phenotypes.耐头孢菌素金黄色葡萄球菌株表现出万古霉素中介耐药表型。
Microbiol Spectr. 2022 Oct 26;10(5):e0256722. doi: 10.1128/spectrum.02567-22. Epub 2022 Sep 29.
7
A vancomycin resistance-associated WalK(S221P) mutation attenuates the virulence of vancomycin-intermediate Staphylococcus aureus.万古霉素耐药相关 WalK(S221P)突变削弱了万古霉素中介金黄色葡萄球菌的毒力。
J Adv Res. 2022 Sep;40:167-178. doi: 10.1016/j.jare.2021.11.015. Epub 2021 Nov 26.
8
Impact of vancomycin use trend change due to the availability of alternative antibiotics on the prevalence of Staphylococcus aureus with reduced vancomycin susceptibility: a 14-year retrospective study.万古霉素使用趋势变化对耐万古霉素金黄色葡萄球菌流行率的影响:一项 14 年回顾性研究。
Antimicrob Resist Infect Control. 2022 Aug 5;11(1):101. doi: 10.1186/s13756-022-01140-9.
9
Antibacterial Profile of a Microbicidal Agent Targeting Tyrosine Phosphatases and Redox Thiols, Novel Drug Targets.一种靶向酪氨酸磷酸酶和氧化还原硫醇(新型药物靶点)的杀菌剂的抗菌谱
Antibiotics (Basel). 2021 Oct 27;10(11):1310. doi: 10.3390/antibiotics10111310.
10
Functional Mapping of Phenotypic Plasticity of Under Vancomycin Pressure.万古霉素压力下的表型可塑性功能图谱
Front Microbiol. 2021 Sep 9;12:696730. doi: 10.3389/fmicb.2021.696730. eCollection 2021.
亚致死浓度抗生素的微生物效应。
Nat Rev Microbiol. 2014 Jul;12(7):465-78. doi: 10.1038/nrmicro3270. Epub 2014 May 27.
4
Dissecting vancomycin-intermediate resistance in staphylococcus aureus using genome-wide association.利用全基因组关联分析剖析金黄色葡萄球菌对万古霉素的中介耐药性
Genome Biol Evol. 2014 Apr 30;6(5):1174-85. doi: 10.1093/gbe/evu092.
5
National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011.2011 年美国侵袭性耐甲氧西林金黄色葡萄球菌感染的国家负担。
JAMA Intern Med. 2013 Nov 25;173(21):1970-8. doi: 10.1001/jamainternmed.2013.10423.
6
The RpoB H₄₈₁Y rifampicin resistance mutation and an active stringent response reduce virulence and increase resistance to innate immune responses in Staphylococcus aureus.RpoB H₄₈₁Y rifampicin 耐药突变和活跃的严格反应降低金黄色葡萄球菌的毒力并增加对先天免疫反应的抵抗力。
J Infect Dis. 2013 Mar 15;207(6):929-39. doi: 10.1093/infdis/jis772. Epub 2012 Dec 18.
7
Contribution of selected gene mutations to resistance in clinical isolates of vancomycin-intermediate Staphylococcus aureus.某些基因突变对耐万古霉素中间葡萄球菌临床分离株耐药性的贡献。
Antimicrob Agents Chemother. 2012 Nov;56(11):5845-51. doi: 10.1128/AAC.01139-12. Epub 2012 Sep 4.
8
Role of stop codons in development and loss of vancomycin non-susceptibility in methicillin-resistant Staphylococcus aureus.终止密码子在耐甲氧西林金黄色葡萄球菌的发育和万古霉素不敏感性丧失中的作用。
J Antimicrob Chemother. 2012 Sep;67(9):2101-6. doi: 10.1093/jac/dks171. Epub 2012 May 29.
9
Genetic pathway in acquisition and loss of vancomycin resistance in a methicillin resistant Staphylococcus aureus (MRSA) strain of clonal type USA300.耐万古霉素金黄色葡萄球菌(MRSA)克隆型 USA300 中获得和丧失万古霉素耐药性的遗传途径。
PLoS Pathog. 2012 Feb;8(2):e1002505. doi: 10.1371/journal.ppat.1002505. Epub 2012 Feb 2.
10
Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR.金黄色葡萄球菌感染过程中多重耐药性的演变涉及必需的双组分调控因子 WalKR 的突变。
PLoS Pathog. 2011 Nov;7(11):e1002359. doi: 10.1371/journal.ppat.1002359. Epub 2011 Nov 10.